| Literature DB >> 20302630 |
Khansa Ben Mansour1, Chédlia Fendri, Meriem Zribi, Afef Masmoudi, Mounir Labbene, Azza Fillali, Nabil Ben Mami, Taoufik Najjar, Ahmed Meherzi, Tahar Sfar, Christophe Burucoa.
Abstract
BACKGROUND: Distinct virulence factors of H. pylori have been described: the vaculating cytotoxin (vacA), the cytotoxin associated gene (cagA), the induced by contact with epithelium factor Antigen (iceA gene) and the outer membrane protein oipA. In Tunisia, there are no data regarding the pattern of H. pylori genotypes; therefore, this prospective and multicentre study was the first to be done in Tunisia and aimed to investigate the prevalence of the vacA, cagA, iceA and oipA genotypes of H. pylori isolates from Tunisian patients with peptic ulceration, gastric cancer, MALT lymphoma and gastritis.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20302630 PMCID: PMC2855517 DOI: 10.1186/1476-0711-9-10
Source DB: PubMed Journal: Ann Clin Microbiol Antimicrob ISSN: 1476-0711 Impact factor: 3.944
PCR primers for amplification of cagA, vacA, iceA and oipA sequences
| Region | Primer | Primer sequence (5'-3') | Size of PCR product (bp) | References |
|---|---|---|---|---|
| F1 | GATAACAGCCAAGCTTTTGAGG | 349 | [ | |
| B1 | CTGCAAAAGATTGTTTGGCAGA | |||
| m1 | VA3-F | GGTCAAAATGCGGTCATGG | 290 | |
| VA3-R | CCATTGGTACCTGTAGAAAC | |||
| m2 | VA4-F | GGAGCCCCAGGAAACATTG | 352 | |
| VA4-R | CATAACTAGCGCCTTGCAC | |||
| s1/s2 | VA1-F | ATGGAAATACAACAAACACAC | 259/286 | [ |
| VA1-R | CTGCTTGAATGCGCCAAAC | |||
| s1b | SS3-R | AGCGCCATACCGCAAGAG | 187 | |
| VA1-R | CTGCTTGAATGCGCCAAAC | |||
| s1a | SS1-R | GTCAGCATCACACCGCAAC | 190 | |
| VA1-R | CTGCTTGAATGCGCCAAAC | |||
| s2 | SS2-R | GCTAACACGCCAAATGATGC | 199 | |
| VA1-R | CTGCTTGAATGCGCCAAAC | |||
| iceA1-F | GTGTTTTTAACCAAAGTATC | 247 | [ | |
| iceA1-R | CTATAGCCASTYTCTTTGCA | |||
| iceA2-F | GTTGGGTATATCACAATTTAT | 229/334 | [ | |
| iceA2-R | TTRCCCTATTTTCTAGTAGGT | |||
| HPO638F | GTTTTTGATGCATGGGATTT | 401 | [ | |
| HPO638R | GTGCATCTCTTATGGCTTT |
Prevalence of H. pylori genotypes detected in strains
| Genotype | Prevalence |
|---|---|
| | 173 (61.6%) |
| | 108 (38.4%) |
| d(A/F)* | 27(9.6%) |
| m1s1a | 5 (1.8%) |
| m1s1b | 25 (8.9%) |
| m2s1a | 10 (3.5%) |
| m2s1b | 25 (8.9%) |
| m2s2 | 128 (45.6%) |
| m1m2 | 88 (31.4%) |
| m1s2 | 0 (0%) |
| d(A/F)* | 13 (4.6%) |
| | 169 (60.2%) |
| | 45(16%) |
| | 67(23.8%) |
| d(A/F)* | 25(8.9%) |
| | 255 (90.8%) |
| | 26 (9.2%) |
| d(A/F)* | 24(8.5%) |
d(A/F)*: discordance between strains isolated from the antrum and the fundus in the same patient
Figure 1Genotyping of . A: example of iceA2 genotyping. Lane 1, negative control without DNA, Lanes 2, 6, 8 and11, iceA2 negative H. pylori strain, Lanes 3, 4 and 13, iceA2 positive H. pylori strain (229-bp), Lanes, 5, 9, 10, 12 and 14, iceA2 positive strain (334-bp), Lane 7,100-bp DNA marker. B: example of oipA genotyping. Lane 1, negative control without DNA, Lanes 2, 5, 6, 10, 11, 13 and 14, oipA positive strains, Lane 7, 100-bp DNA marker, Lanes 3, 4, 8, 9 and 12, oipA negative strains.
Combined vacA, cagA, iceA and oipA genotypes
| Combination | DU* | GU* | G* | Total |
|---|---|---|---|---|
| s1/ | 4(20%) | 4(100%) | 7(6.5%) | 13(9.9%) |
| s1/ | 4(20%) | 0(0%) | 4(3.7%) | 8(6.1%) |
| s1/ | 8(40%) | 0(0%) | 3(2.8%) | 11(8.4%) |
| s1/ | 1(5%) | 0(0%) | 4(3.7%) | 5(3.8%) |
| s1/ | 2(10%) | 0(0%) | 1(0.9%) | 3(2.3%) |
| s2/ | 1(5%) | 0(0%) | 35(32.7%) | 36(27.5%) |
| s2/ | 0(0%) | 0(0%) | 15(14%) | 15(11.4%) |
| s2/ | 0(0%) | 0(0%) | 31(29%) | 31(23.6%) |
| s2/ | 0(0%) | 0(0%) | 4(3.7%) | 4(3%) |
| s2/ | 0(0%) | 0(0%) | 5(4.6%) | 5(3.8%) |
| Total | 20 | 4 | 107 | 131 |
DU*: duodenal ulcer; GU*: gastric ulcer; G*: gastritis
cagA, vacA, iceA and oipA status of H. pylori strains with different gastric diseases: a comparison between patients with peptic ulceration, and with gastritis
| PU* | G* | ||
|---|---|---|---|
| cagA+ | 53 (67.9%) | 114 (58.4%) | > 0.05 |
| oipA+ | 63 (80.7%) | 186 (95.3%) | < 0.001 |
| iceA1 | 51 (65.3%) | 113 (57.9%) | > 0.05 |
| iceA2 | 12 (15.3%) | 33 (16.9%) | |
| iceA1/A2 | 15 (19.2%) | 49 (25.1%) | |
| m1s1 | 12 (15.3%) | 18 (9.2%) | < 0.001 |
| m2s1 | 17 (21.8%) | 17 (8.7%) | |
| m1m2 | 49 (62.8%) | 32 (16.4%) | |
| m2s2 | 0 (0%) | 128 (65.6%) |
PU*: peptic ulceration; G*: gastritis
Relation between the age of patients and virulence factors:
| Adults | Children | ||
|---|---|---|---|
| 155 | 18 | < 0.001 | |
| 209 | 46 | > 0.05 | |
| 137 | 32 | 0.05 | |
| 43 | 2 | ||
| iceA1/iceA2 | 53 | 14 | |
| m1s1 | 26 | 4 | > 0.05 |
| m2s1 | 31 | 4 | |
| m1m2 | 72 | 16 | |
| m2s2 | 104 | 24 |
Relation between the sex of patients and virulence factors:
| Male | Female | ||
|---|---|---|---|
| 84 | 89 | > 0.05 | |
| 111 | 144 | < 0.05 | |
| 78 | 91 | ||
| 17 | 28 | 0.05 | |
| iceA1/iceA2 | 40 | 27 | |
| m1s1 | 19 | 11 | |
| m2s1 | 19 | 16 | < 0.001 |
| m1/m2 | 49 | 39 | |
| m2s2 | 40 | 88 |